Krystal Biotech (KRYS) Net Margin (2021 - 2025)
Historic Net Margin for Krystal Biotech (KRYS) over the last 4 years, with Q4 2025 value amounting to 47.98%.
- Krystal Biotech's Net Margin fell 19700.0% to 47.98% in Q4 2025 from the same period last year, while for Dec 2025 it was 52.62%, marking a year-over-year increase of 219300.0%. This contributed to the annual value of 52.64% for FY2025, which is 219500.0% up from last year.
- Latest data reveals that Krystal Biotech reported Net Margin of 47.98% as of Q4 2025, which was down 19700.0% from 81.15% recorded in Q3 2025.
- Krystal Biotech's Net Margin's 5-year high stood at 1059.79% during Q1 2021, with a 5-year trough of 2.06% in Q1 2024.
- In the last 4 years, Krystal Biotech's Net Margin had a median value of 40.47% in 2025 and averaged 212.75%.
- Per our database at Business Quant, Krystal Biotech's Net Margin tumbled by -9113400bps in 2024 and then skyrocketed by 487500bps in 2025.
- Krystal Biotech's Net Margin (Quarter) stood at 1059.79% in 2021, then plummeted by -98bps to 20.62% in 2023, then skyrocketed by 142bps to 49.95% in 2024, then fell by -4bps to 47.98% in 2025.
- Its last three reported values are 47.98% in Q4 2025, 81.15% for Q3 2025, and 39.91% during Q2 2025.